Renovascular hypertension (RH) is a pathological condition caused by narrowing or occlusion of the arteries supplying the kidneys, which leads to impaired regulation of blood pressure. This disease is considered one of the forms of secondary arterial hypertension and is often associated with atherosclerosis or vascular dysplasia. The mechanism of RH development is based on decreased renal perfusion, which activates the renin-angiotensin system and water-salt retention, resulting in an increase in overall arterial pressure. Renovascular hypertension can manifest itself as high blood pressure that is resistant to traditional antihypertensive therapy, and can also be accompanied by other clinical manifestations such as low back pain, changes in renal function, and deterioration of general well-being.
History of the disease and interesting historical facts
Renovascular hypertension was first described in the early 20th century when physicians began to associate kidney problems with the development of hypertension. Initial studies focused on identifying the causes of high blood pressure and its relationship to kidney function. Research in the 1930s helped advance understanding of the role of the renin-angiotensin system in the pathogenesis of renovascular hypertension. In the 1950s, the development of angiography made it possible to visualize the vessels, which contributed to a more accurate diagnosis and understanding of the disease. Moreover, experimental studies in animal models showed that narrowing of the renal arteries causes hypertension, which in turn spurred further research into the role of surgical interventions in the treatment of this pathology.
Epidemiology
According to current data, renovascular hypertension accounts for about 5-10% cases of secondary arterial hypertension, which suggests a significant time of undiagnosed or misdiagnosed disease. According to the World Health Organization, the workload of a physician examining patients with hypertension has increased significantly, especially in the older age group, where the prevalence is up to 20%. Moreover, the risk of atherosclerosis increases with age, which is associated with an increased incidence of RG. These studies also show that men are at higher risk of developing RG than women, which may be due to differences in the pathogenesis of vascular diseases and their risk factors.
Genetic predisposition to this disease
Some genetic factors may influence the development of renovascular hypertension. Research shows that certain mutations in genes associated with vascular tone and regulation of the renin-angiotensin system may increase the risk of this disease. These genes include:
- AGT (angiotensinogen gene)
- ACE (angiotensin-converting enzyme gene)
- AGTR1 (angiotensin II receptor gene)
These mutations can alter the function of the system, leading to increased blood pressure. There are also studies linking genetic predisposition to underlying conditions such as diabetes and metabolic syndrome, which can worsen the course of RG.
Risk factors for the development of this disease
There are several risk factors that may contribute to the development of renovascular hypertension. These include:
- Atherosclerosis, which is the main etiopathogenetic factor of RG in old age.
- Age: The risk increases after age 50.
- A family history of hypertension.
- Smoking and alcohol abuse.
- Diabetes mellitus and metabolic syndrome.
- Elevated levels of cholesterol and triglycerides in the blood.
- The use of oral contraceptives in women, which is associated with the prolonged effect of estrogens on blood vessels.
Knowledge of these risk factors allows for earlier detection and prevention of the disease.
Diagnosis of this disease
Diagnosis of renovascular hypertension involves a comprehensive approach with an emphasis on the following:
- Main symptoms: High blood pressure that is difficult to diagnose with conventional antihypertensive drugs, as well as possible signs of kidney failure.
- Laboratory tests: Determination of creatinine levels, electrolytes, and analysis of renin and aldosterone.
- Radiological examinations: Ultrasound of the kidneys, angiography and computed tomography to detect anatomical changes in the renal arteries.
- Other types of disease diagnostics: MRI with contrast and renal scintigraphy to assess function.
- Differential diagnosis: It is important to exclude other forms of secondary hypertension and primary hypertension.
The combination of clinical data and diagnostic results allows for a correct diagnosis and treatment planning.
Treatment
Treatment of renovascular hypertension requires an individualized approach, which may include:
- General treatment: Monitoring blood pressure, regular medical check-ups and lifestyle changes (diet, physical activity).
- Pharmacological treatment: Use of antihypertensive drugs such as ACE inhibitors, angiotensin receptor blockers, and diuretics.
- Surgical treatment: Angioplasty or stenting of the renal arteries, and in some cases, surgical revascularization.
- Other types of treatment: In some cases, the method of renal artery obliteration is used.
It is important to note that the choice of treatment method depends on the severity of the disease and the individual characteristics of the patient.
List of medications used to treat this disease
The following groups of drugs are actively used to control renovascular hypertension:
- Angiotensin-converting enzyme (ACE) inhibitors: enalapril, lisinopril.
- Angiotensin II receptor blockers: losartan, valsartan.
- Diuretics: hydrochlorothiazide, furosemide.
- Beta blockers: atenolol, metoprolol.
- Calcium antagonists: amlodipine, diltiazem.
A personalized approach to choosing drug therapy helps achieve optimal blood pressure control.
Disease monitoring
Renovascular hypertension monitoring includes:
- Control stages: Regular monitoring of blood pressure, assessment of kidney function and laboratory tests.
- Forecast: With early diagnosis and adequate treatment, normalization of blood pressure and improvement of kidney function are possible.
- Complications: Progression of renal failure and cardiovascular complications in the form of heart attacks and strokes are possible.
Prompt intervention and patient support at all stages of treatment are important.
Age-related features of the disease
Renovascular hypertension manifests itself differently depending on the patient’s age. In young people, it is often associated with congenital anomalies of the renal arteries. In middle-aged people, RG often develops against the background of atherosclerosis, while in elderly patients, the risk of renal ischemia predominates. In children, the disease may be associated with dysplasia or stenosis of the renal arteries. Differences in manifestations require adaptation of diagnostic and therapeutic strategies based on the patient’s age category.
Questions and Answers
- What is renovascular hypertension? Renovascular hypertension is a condition caused by narrowing of the renal arteries, leading to high blood pressure.
- How is renovascular hypertension diagnosed? Diagnosis involves evaluation of symptoms, laboratory tests, and radiological studies such as ultrasound and angiography.
- What risk factors contribute to the development of renovascular hypertension? The main risk factors include atherosclerosis, smoking, diabetes and age over 50 years.
- What treatments are used for renovascular hypertension? Treatment may include drug therapy, angioplasty, or surgical revascularization.
- What is the prognosis for renovascular hypertension? The prognosis depends on the stage of the disease, but with adequate treatment, improvement in the condition and control of blood pressure are possible.
